Sleep Disorders News

Patients with moderate to severe obstructive sleep apnea and no use of continuous positive airway pressure had higher rates of cardiovascular disease than patients who did use continuous positive airway pressure for any length of time.

CPAP therapy may have a protective effect on adverse cardiovascular outcomes in patients with coronary artery disease and nonsleepy obstructive sleep apnea who have greater heart rate responses to sleep apnea events.

In this video, Dennis Hwang, MD, discusses results of a study that analyzed the relationship between obstructive sleep apnea, adherence to positive airway pressure therapy and risk for COVID-19 infection.

The Healio Editors have compiled a list of the most-read news in pulmonology posted in May.

A new study found that obstructive sleep apnea is associated with increased risk for COVID-19 infection, and greater adherence to positive airway pressure therapy was associated with reduced risk for infection.

Tailored interventions that address pain, anxiety, fatigue or perceived stress may benefit women with breast cancer who experience sleep disturbance, according to study results presented at the virtual Oncology Nursing Society Congress.

The Healio Editors have compiled a list of the most-read news in pulmonology published in April.

CPAP therapy may have an effect on BMI in adults with obstructive sleep apnea, especially among those with poorer adherence, researchers reported in the Annals of the American Thoracic Society.

Among individual shift workers, circadian rhythm misalignment was associated with elevated CV risk, according to results presented at the European Society of Cardiology preventive cardiology meeting.

This week, the benefits of using telemedicine to address sleep disorders and provide cystic fibrosis care; rituximab may be an effective adjuvant treatment for systemic sclerosis and PAH; the FDA says facilities should move away from crisis capacity conservation measures; and researchers call for standardization to identify and categorize environmental exposures when assessing interstitial lung disease progression.